News & Events about Immunogen Inc.
Stock Options Channel
25days ago
Investors in ImmunoGen, Inc. (IMGN) saw new options become available today, for the January 2025 expiration...
Thinking about buying stock in ImmunoGen, Mersana Therapeutics, Unisys, Eyepoint Pharmaceuticals, or BioCryst Pharmaceuticals? Thinking about buying stock in ImmunoGen, Mersana Therapeutics, Unisys, Eyepoint Pharmaceuticals, or BioCryst Pharmaceuticals? PR Newswire NEW YORK, May 3, 2023 NEW YORK...
Thinking about buying stock in ImmunoGen, Intel, Vuzix, eMagin, or Weibo? Thinking about buying stock in ImmunoGen, Intel, Vuzix, eMagin, or Weibo? PR Newswire NEW YORK, April 28, 2023 NEW YORK, April 28, 2023 /PRNewswire/ -- InvestorsObserverissues critical PriceWatch Alerts for IMGN, INTC, VUZI...
ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today reviewed recent progress in the business and reported financial results for the quarter ended March 31, 2023. With a strong first full quarter of sales and continued...